ArticleOncotarget2016

Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.

Hanna Taipaleenmäki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.